Navigation Links
Still River Systems Announces Operation of the World's Highest Magnetic Field Cyclotron
Date:5/21/2008

LITTLETON, Mass., May 21 /PRNewswire/ -- Still River Systems announces the successful development and operation of the world's highest magnetic field cyclotron as part of the development of its Monarch250(TM) proton therapy system. This cyclotron is operating at 10 Tesla and conclusively demonstrates that cyclotrons at this high field strength can be designed and optimized for proton radiation therapy. By increasing the operating magnetic field, Still River Systems is developing a cyclotron that weighs less than 20 tons, a 90% reduction over the current generation of proton therapy cyclotrons. "We are excited to report this technical breakthrough," says Kenneth Gall, Ph.D., Chief Technology Officer and Founder of Still River Systems. "While magnets of this strength are already in use in medical applications, the challenge has been to operate a cyclotron at this very large magnetic field."

Conventional proton radiation therapy cyclotrons are based on non-superconducting technology, and operate at low magnetic fields. In 2004, Still River Systems partnered with the Massachusetts Institute of Technology (MIT) to develop this next generation of proton therapy cyclotron using high magnetic field technology currently used in research and Magnetic Resonance Imaging (MRI) applications. "Our goal is to make proton radiation therapy treatment available to hospitals and cancer centers worldwide. This was only possible through a significant reduction in the cost and size of the proton therapy equipment and facility which can be achieved by using high-magnetic field technology," says Marc Buntaine, Chief Executive Officer of Still River Systems.

About The Monarch250

The Monarch250 is the next generation of proton radiation therapy systems. Based on Still River Systems high-magnetic field cyclotron, combined with proven proton therapy technology, the Monarch250 is being integrated with well established clinical systems such as patient radiographic and cone beam CT imaging, high-precision robotic treatment couch, oncology information systems and treatment planning systems. The compact, precise and affordable design of the Monarch250 proton therapy system provides the most versatile proton treatment capabilities, enhancing existing department capacity. For large multiple room proton centers, the Monarch250 unique configuration of one-cyclotron for each room will provide the most reliable, efficient and economical approach to proton therapy. The Monarch250 has not been cleared for commercial distribution/clinical use by the US Food and Drug Administration and is currently in development.

About Still River Systems

Still River Systems, based in Littleton, Massachusetts, is dedicated to providing physicians and their patients access to high quality, cost-effective proton therapy solutions, and to help establish this superior treatment modality as a standard of care for patients worldwide. Still River Systems is developing the Monarch250, an affordable, precise and compact proton therapy system for cancer treatment. For more information on Still River Systems and the Monarch250 Proton Therapy System, please call 978-540-1500 or visit their website @ http://www.StillRiverSystems.com.


'/>"/>
SOURCE Still River Systems
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
2. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
3. Lethal Human H5N1 Influenza Virus Replikin Gene Still Upregulated
4. Federal nanotech risk research plan still comes up short
5. RiverVest Venture Partners(R), a St. Louis-Based Venture Capital Firm Focusing on Life Sciences, Closes on Fund II, Names John P. McKearn, Ph.D., Venture Partner
6. Dr. Arie S. Belldegrun, MD, FACS Joins Two River Group Holdings as Chairman and Partner
7. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
8. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
9. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
10. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
11. NxStage Medical Provides Update on Medisystems Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)... ... 2016 , ... Newly created 4Sight Medical Solutions ... healthcare market. The company's primary focus is on new product introductions, to include ... are necessary to help companies efficiently bring their products to market. , The ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
Breaking Biology News(10 mins):